Liquid biopsy of gastric cancer patients: Circulating tumor cells and cell-free nucleic acids

World Journal of Gastroenterology

Volumn 20, Issue 12, 2014, Pages 3265-3286

  Tsujiura, Masahiro ^a   Ichikawa, Daisuke ^a   Konishi, Hirotaka ^a   Komatsu, Shuhei ^a   Shiozaki, Atsushi ^a   Otsuji, Eigo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Biomarker; Cell free nucleic acids; Circulating tumor cells; Gastric cancer; Liquid biopsy; MicroR NA

Indexed keywords

BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CD45 ANTIGEN; CELL FREE NUCLEIC ACID; COMPLEMENTARY DNA; CYTOKERATIN; DNA; EPITHELIAL CELL ADHESION MOLECULE; MATRIX METALLOPROTEINASE; MESSENGER RNA; MICRORNA; MUCIN 1; MUCIN 2; NUCLEIC ACID; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; TUMOR MARKER;

CANCER GROWTH; CARCINOGENESIS; CELL FUNCTION; CELL ISOLATION; CHROMATIN IMMUNOPRECIPITATION; CIRCULATING TUMOR CELL; CONTROLLED STUDY; DNA EXTRACTION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; REVIEW; RNA EXTRACTION; STOMACH CANCER; TUMOR BIOPSY; BIOPSY; BLOOD; CELL FREE SYSTEM; GENETIC EPIGENESIS; METABOLISM; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; STOMACH NEOPLASMS; TREATMENT OUTCOME; TUMOR EMBOLISM;

BIOPSY; CELL-FREE SYSTEM; DNA, NEOPLASM; EPIGENESIS, GENETIC; HUMANS; MICRORNAS; NEOPLASTIC CELLS, CIRCULATING; NUCLEIC ACIDS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; STOMACH NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84896921561     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i12.3265     Document Type: Review

References (187)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Alix-Panabières C, Pantel K. Circulating tumor cells: liquid biopsy of cancer. Clin Chem 2013; 59: 110-118 [PMID: 23014601 DOI: 10.1373/clinchem.2012.194258]
3. van de Stolpe A, Pantel K, Sleijfer S, Terstappen LW, den Toonder JM. Circulating tumor cell isolation and diagnostics: toward routine clinical use. Cancer Res 2011; 71: 5955-5960 [PMID: 21896640 DOI: 10.1158/0008-5472.CAN-11-1254]
4. Crowley E, Di Nicolantonio F, Loupakis F, Bardelli A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol 2013; 10: 472-484 [PMID: 23836314 DOI: 10.1038/ nrclinonc.2013.110]
5. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011; 11: 426-437 [PMID: 21562580 DOI: 10.1038/nrc3066]
6. Ashworth T. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aust Med J 1869; 14: 146-149
7. Ghossein RA, Bhattacharya S, Rosai J. Molecular detection of micrometastases and circulating tumor cells in solid tumors. Clin Cancer Res 1999; 5: 1950-1960 [PMID: 10473071]
8. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004; 10: 6897-6904 [PMID: 15501967 DOI: 10.1158/1078-0432.CCR-04-0378]
9. Zheng S, Lin H, Liu JQ, Balic M, Datar R, Cote RJ, Tai YC. Membrane microfilmed device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A 2007; 1162: 154-161 [PMID: 17561026 DOI: 10.1016/j.chroma.2007.05.064]
10. Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schütze K, Capron F, Franco D, Pazzagli M, Vekemans M, Lacour B, Bréchot C, Paterlini-Bréchot P. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am J Pathol 2000; 156: 57-63 [PMID: 10623654 DOI: 10.1016/ S0002-9440(10)64706-2]
11. Coumans FA, van Dalum G, Beck M, Terstappen LW. Filter characteristics infuencing circulating tumor cell enrichment from whole blood. PLoS One 2013; 8: e61770 [PMID: 23626725 DOI: 10.1371/journal.pone.0061770]
12. Coumans FA, van Dalum G, Beck M, Terstappen LW. Filtration parameters influencing circulating tumor cell enrichment from whole blood. PLoS One 2013; 8: e61774 [PMID: 23658615 DOI: 10.1371/journal.pone.0061774]
13. Marrinucci D, Bethel K, Bruce RH, Curry DN, Hsieh B, Humphrey M, Krivacic RT, Kroener J, Kroener L, Ladanyi A, Lazarus NH, Nieva J, Kuhn P. Case study of the morphologic variation of circulating tumor cells. Hum Pathol 2007; 38: 514-519 [PMID: 17188328 DOI: 10.1016/j.hump-ath.2006.08.027]
14. Tan SJ, Yobas L, Lee GY, Ong CN, Lim CT. Microdevice for the isolation and enumeration of cancer cells from blood. Biomed Microdevices 2009; 11: 883-892 [PMID: 19387837 DOI: 10.1007/s10544-009-9305-9]
15. Mohamed H, Murray M, Turner JN, Caggana M. Isolation of tumor cells using size and deformation. J Chromatogr A 2009; 1216: 8289-8295 [PMID: 19497576 DOI: 10.1016/ j.chroma.2009.05.036]
16. Munz M, Baeuerle PA, Gires O. The emerging role of Ep-CAM in cancer and stem cell signaling. Cancer Res 2009; 69: 5627-5629 [PMID: 19584271 DOI: 10.1158/0008-5472. CAN-09-0654]
17. van der Gun BT, Melchers LJ, Ruiters MH, de Leij LF, McLaughlin PM, Rots MG. EpCAM in carcinogenesis: the good, the bad or the ugly. Carcinogenesis 2010; 31: 1913-1921 [PMID: 20837599 DOI: 10.1093/carcin/bgq187]
18. Wenqi D, Li W, Shanshan C, Bei C, Yafei Z, Feihu B, Jie L, Daiming F. EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer. J Cancer Res Clin Oncol 2009; 135: 1277-1285 [PMID: 19294417 DOI: 10.1007/s00432-009-0569-5]
19. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351: 781-791 [PMID: 15317891 DOI: 10.1056/NEJMoa040766]
20. Danila DC, Heller G, Gignac GA, Gonzalez-Espinoza R, Anand A, Tanaka E, Lilja H, Schwartz L, Larson S, Fleisher M, Scher HI. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 2007; 13: 7053-7058 [PMID: 18056182 DOI: 10.1158/1078-0432.CCR-07-1506]
21. Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV, Terstappen LW. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 2006; 12: 4218-4224 [PMID: 16857794 DOI: 10.1158/1078-0432. CCR-05-2821]
22. Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007; 13: 920-928 [PMID: 17289886 DOI: 10.1158/1078-0432.CCR-06-1695]
23. Sastre J, Maestro ML, Puente J, Veganzones S, Alfonso R, Rafael S, García-Saenz JA, Vidaurreta M, Martín M, Arroyo M, Sanz-Casla MT, Díaz-Rubio E. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 2008; 19: 935-938 [PMID: 18212090 DOI: 10.1093/annonc/mdm583]
24. Shaffer DR, Leversha MA, Danila DC, Lin O, Gonzalez-Espinoza R, Gu B, Anand A, Smith K, Maslak P, Doyle GV, Terstappen LW, Lilja H, Heller G, Fleisher M, Scher HI. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Clin Cancer Res 2007; 13: 2023-2029 [PMID: 17404082 DOI: 10.1158/1078-0432. CCR-06-2701]
25. Thompson EW, Haviv I. The social aspects of EMT-MET plasticity. Nat Med 2011; 17: 1048-1049 [PMID: 21900919 DOI: 10.1038/nm.2437]
26. Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Branni-gan B, Collura CV, Inserra E, Diederichs S, Iafrate AJ, Bell DW, Digumarthy S, Muzikansky A, Irimia D, Settleman J, Tompkins RG, Lynch TJ, Toner M, Haber DA. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 2008; 359: 366-377 [PMID: 18596266 DOI: 10.1056/NEJ-Moa0800668]
27. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007; 450: 1235-1239 [PMID: 18097410 DOI: 10.1038/nature06385]
28. Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, Inserra EJ, Ulman M, Springer S, Nakamura Z, Moore AL, Tsukrov DI, Kempner ME, Dahl DM, Wu CL, Iafrate AJ, Smith MR, Tompkins RG, Sequist LV, Toner M, Haber DA, Maheswaran S. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med 2010; 2: 25ra23 [PMID: 20424012 DOI: 10.1126/scitranslmed.3000403]
29. Sakaizawa K, Goto Y, Kiniwa Y, Uchiyama A, Harada K, Shimada S, Saida T, Ferrone S, Takata M, Uhara H, Okuyama R. Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level. Br J Cancer 2012; 106: 939-946 [PMID: 22281663 DOI: 10.1038/bjc.2012.12]
30. Heitzer E, Auer M, Gasch C, Pichler M, Ulz P, Hoffmann EM, Lax S, Waldispuehl-Geigl J, Mauermann O, Lackner C, Höfer G, Eisner F, Sill H, Samonigg H, Pantel K, Riethdorf S, Bauernhofer T, Geigl JB, Speicher MR. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res 2013; 73: 2965-2975 [PMID: 23471846 DOI: 10.1158/0008-5472. can-12-4140]
31. Cann GM, Gulzar ZG, Cooper S, Li R, Luo S, Tat M, Stuart S, Schroth G, Srinivas S, Ronaghi M, Brooks JD, Talasaz AH. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. PLoS One 2012; 7: e49144 [PMID: 23145101 DOI: 10.1371/journal.pone.0049144]
32. Saucedo-Zeni N, Mewes S, Niestroj R, Gasiorowski L, Mu-rawa D, Nowaczyk P, Tomasi T, Weber E, Dworacki G, Mor-genthaler NG, Jansen H, Propping C, Sterzynska K, Dyszkie-wicz W, Zabel M, Kiechle M, Reuning U, Schmitt M, Lücke K. A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a func-tionalized and structured medical wire. Int J Oncol 2012; 41: 1241-1250 [PMID: 22825490 DOI: 10.3892/ijo.2012.1557]
33. Krivacic RT, Ladanyi A, Curry DN, Hsieh HB, Kuhn P, Bergsrud DE, Kepros JF, Barbera T, Ho MY, Chen LB, Le-rner RA, Bruce RH. A rare-cell detector for cancer. Proc Natl Acad Sci USA 2004; 101: 10501-10504 [PMID: 15249663 DOI: 10.1073/pnas.0404036101]
34. Hsieh HB, Marrinucci D, Bethel K, Curry DN, Humphrey M, Krivacic RT, Kroener J, Kroener L, Ladanyi A, Lazarus N, Kuhn P, Bruce RH, Nieva J. High speed detection of circulating tumor cells. Biosens Bioelectron 2006; 21: 1893-1899 [PMID: 16464570 DOI: 10.1016/j.bios.2005.12.024]
35. Alix-Panabières C. EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients. Recent Results Cancer Res 2012; 195: 69-76 [PMID: 22527495 DOI: 10.1007/978-3-642 -28160-0_6]
36. Alix-Panabières C, Vendrell JP, Pellé O, Rebillard X, Rieth-dorf S, Müller V, Fabbro M, Pantel K. Detection and characterization of putative metastatic precursor cells in cancer patients. Clin Chem 2007; 53: 537-539 [PMID: 17327507 DOI: 10.1373/clinchem.2006.079509]
37. Alix-Panabières C, Vendrell JP, Slijper M, Pellé O, Barbotte E, Mercier G, Jacot W, Fabbro M, Pantel K. Full-length cyto-keratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer. Breast Cancer Res 2009; 11: R39 [PMID: 19549321 DOI: 10.1186/bcr2326]
38. Pantel K, Alix-Panabières C, Riethdorf S. Cancer microme-tastases. Nat Rev Clin Oncol 2009; 6: 339-351 [PMID: 19399023 DOI: 10.1038/nrclinonc.2009.44]
39. Sieuwerts AM, Mostert B, Bolt-de Vries J, Peeters D, de Jongh FE, Stouthard JM, Dirix LY, van Dam PA, Van Galen A, de Weerd V, Kraan J, van der Spoel P, Ramírez-Moreno R, van Deurzen CH, Smid M, Yu JX, Jiang J, Wang Y, Gratama JW, Sleijfer S, Foekens JA, Martens JW. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clin Cancer Res 2011; 17: 3600-3618 [PMID: 21505063 DOI: 10.1158/1078-0432.CCR-11-0255]
40. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Weiner LM, Cohen SJ, Moreno JG, Connelly MC, Terstappen LW, O'Hara SM. Global gene expression profiling of circulating tumor cells. Cancer Res 2005; 65: 4993-4997 [PMID: 15958538 DOI: 10.1158/0008-5472. CAN-04-4330]
41. Sieuwerts AM, Kraan J, Bolt-de Vries J, van der Spoel P, Mostert B, Martens JW, Gratama JW, Sleijfer S, Foekens JA. Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex realtime PCR. Breast Cancer Res Treat 2009; 118: 455-468 [PMID: 19115104 DOI: 10.1007/s10549-008-0290-0]
42. Uen YH, Lin SR, Wu CH, Hsieh JS, Lu CY, Yu FJ, Huang TJ, Wang JY. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma. Clin Chim Acta 2006; 367: 55-61 [PMID: 16403482 DOI: 10.1016/j.cca.2005.11.013]
43. Wu CH, Lin SR, Hsieh JS, Chen FM, Lu CY, Yu FJ, Cheng TL, Huang TJ, Huang SY, Wang JY. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance. Dis Markers 2006; 22: 103-109 [PMID: 16788243]
44. Wu CH, Lin SR, Yu FJ, Wu DC, Pan YS, Hsieh JS, Huang SY, Wang JY. Development of a high-throughput membrane-array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers. Int J Cancer 2006; 119: 373-379 [PMID: 16477642 DOI: 10.1002/ijc.21856]
45. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838 [PMID: 15944708 DOI: 10.1038/nature03702]
46. Croce CM. Causes and consequences of microRNA dys-regulation in cancer. Nat Rev Genet 2009; 10: 704-714 [PMID: 19763153 DOI: 10.1038/nrg2634]
47. Mei Y, Clark D, Mao L. Novel dimensions of piRNAs in cancer. Cancer Lett 2013; 336: 46-52 [PMID: 23603435 DOI: 10.1016/j.canlet.2013.04.008]
48. Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z, Cheng J, Xiao BX. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl) 2010; 88: 709-717 [PMID: 20349219 DOI: 10.1007/s00109-010-0617-2]
49. Cui L, Lou Y, Zhang X, Zhou H, Deng H, Song H, Yu X, Xiao B, Wang W, Guo J. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers. Clin Biochem 2011; 44: 1050-1057 [PMID: 21704610 DOI: 10.1016/j.clinbiochem.2011.06.004]
50. Zheng Y, Cui L, Sun W, Zhou H, Yuan X, Huo M, Chen J, Lou Y, Guo J. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients. Cancer Biomark 2011; 10: 71-77 [PMID: 22430134 DOI: 10.3233/CBM-2011-0231]
51. Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, Iglesias-Díaz P, Lorenzo-Patiño MJ, Haz M, Santamarina I, Blanco M, Fernández-Tajes J, Quindós M, Carral A, Figueroa A, Antón-Aparicio LM, Calvo L. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med 2012; 10: 186 [PMID: 22954417 DOI: 10.1186/1479 -5876-10-186]
52. Zhou H, Xiao B, Zhou F, Deng H, Zhang X, Lou Y, Gong Z, Du C, Guo J. MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients. Biomarkers 2012; 17: 104-110 [PMID: 22263628 DOI: 10.3109/1354750X.2011.61496 1]
53. Duttagupta R, Jiang R, Gollub J, Getts RC, Jones KW. Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 2011; 6: e20769 [PMID: 21698099 DOI: 10.1371/journal.pone.0020769]
54. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, Tait JF, Tewari M. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 2012; 5: 492-497 [PMID: 22158052 DOI: 10.1158/1940-6207.capr-11-0370]
55. Hiraiwa K, Takeuchi H, Hasegawa H, Saikawa Y, Suda K, Ando T, Kumagai K, Irino T, Yoshikawa T, Matsuda S, Kitajima M, Kitagawa Y. Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol 2008; 15: 3092-3100 [PMID: 18766405 DOI: 10.1245/s10434-008-0122-9]
56. Matsusaka S, Chìn K, Ogura M, Suenaga M, Shinozaki E, Mishima Y, Terui Y, Mizunuma N, Hatake K. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer. Cancer Sci 2010; 101: 1067-1071 [PMID: 20219073 DOI: 10.1111/ j.1349-7006.2010.01492.x]
57. Mimori K, Fukagawa T, Kosaka Y, Ishikawa K, Iwatsuki M, Yokobori T, Hirasaki S, Takatsuno Y, Sakashita H, Ishii H, Sasako M, Mori M. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases. Ann Surg Oncol 2008; 15: 2934-2942 [PMID: 18661187 DOI: 10.1245/s10434-008-9916-z]
58. Ikeguchi M, Kaibara N. Detection of circulating cancer cells after a gastrectomy for gastric cancer. Surg Today 2005; 35: 436-441 [PMID: 15912289 DOI: 10.1007/s00595-004-2978-z]
59. Miyazono F, Natsugoe S, Takao S, Tokuda K, Kijima F, Aridome K, Hokita S, Baba M, Eizuru Y, Aikou T. Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery. Ann Surg 2001; 233: 189-194 [PMID: 11176124]
60. Nishida S, Kitamura K, Ichikawa D, Koike H, Tani N, Yam-agishi H. Molecular detection of disseminated cancer cells in the peripheral blood of patients with gastric cancer. Antican-cer Res 2000; 20: 2155-2159 [PMID: 10928170]
61. Pituch-Noworolska A, Kolodziejczyk P, Kulig J, Drabik G, Szczepanik A, Czupryna A, Popiela T, Zembala M. Circulating tumour cells and survival of patients with gastric cancer. Anticancer Res 2007; 27: 635-640 [PMID: 17348453]
62. Mandel P, Metais P. [Les acides nucleiques du plasma sanguin chez l'homme]. C R Seances Soc Biol Fil 1948; 142: 241-243 [PMID: 18875018]
63. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977; 37: 646-650 [PMID: 837366]
64. Vasioukhin V, Anker P, Maurice P, Lyautey J, Lederrey C, Stroun M. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol 1994; 86: 774-779 [PMID: 7918071]
65. Sorenson GD, Pribish DM, Valone FH, Memoli VA, Bzik DJ, Yao SL. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomark-ers Prev 1994; 3: 67-71 [PMID: 8118388]
66. Choi JJ, Reich CF, Pisetsky DS. The role of macrophages in the in vitro generation of extracellular DNA from apop-totic and necrotic cells. Immunology 2005; 115: 55-62 [PMID: 15819697 DOI: 10.1111/j.1365-2567.2005.02130.x]
67. Pisetsky DS, Fairhurst AM. The origin of extracellular DNA during the clearance of dead and dying cells. Autoimmunity 2007; 40: 281-284 [PMID: 17516210 DOI: 10.1080/0891693070 1358826]
68. Stroun M, Lyautey J, Lederrey C, Mulcahy HE, Anker P. Alu repeat sequences are present in increased proportions compared to a unique gene in plasma/serum DNA: evidence for a preferential release from viable cells? Ann N Y Acad Sci 2001; 945: 258-264 [PMID: 11708488]
69. Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 2001; 313: 139-142 [PMID: 11694251]
70. Trejo-Becerril C, Pérez-Cárdenas E, Taja-Chayeb L, Anker P, Herrera-Goepfert R, Medina-Velázquez LA, Hidalgo-Miranda A, Pérez-Montiel D, Chávez-Blanco A, Cruz-Velázquez J, Díaz-Chávez J, Gaxiola M, Dueñas-González A. Cancer progression mediated by horizontal gene transfer in an in vivo model. PLoS One 2012; 7: e52754 [PMID: 23285175 DOI: 10.1371/journal.pone.0052754]
71. García-Olmo DC, Domínguez C, García-Arranz M, Anker P, Stroun M, García-Verdugo JM, García-Olmo D. Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells. Cancer Res 2010; 70: 560-567 [PMID: 20068178 DOI: 10.1158/0008-5472.CAN-09-3513]
72. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010; 285: 17442-17452 [PMID: 20353945 DOI: 10.1074/jbc.M110.107821]
73. Wang BG, Huang HY, Chen YC, Bristow RE, Kassauei K, Cheng CC, Roden R, Sokoll LJ, Chan DW, Shih IeM. Increased plasma DNA integrity in cancer patients. Cancer Res 2003; 63: 3966-3968 [PMID: 12873992]
74. Suzuki N, Kamataki A, Yamaki J, Homma Y. Characterization of circulating DNA in healthy human plasma. Clin Chim Acta 2008; 387: 55-58 [PMID: 17916343 DOI: 10.1016/ j.cca.2007.09.001]
75. Diehl F, Li M, Dressman D, He Y, Shen D, Szabo S, Diaz LA, Goodman SN, David KA, Juhl H, Kinzler KW, Vogelstein B. Detection and quantifcation of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci USA 2005; 102: 16368-16373 [PMID: 16258065 DOI: 10.1073/ pnas.0507904102]
76. van 'T Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. Gene expression profling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-536 [PMID: 11823860 DOI: 10.1038/415530a]
77. Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B, Rajan S, Humphray S, Becq J, Halsall D, Wallis M, Bentley D, Caldas C, Rosenfeld N. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 2013; 368: 1199-1209 [PMID: 23484797 DOI: 10.1056/NEJMoa1213261]
78. Chan KC, Jiang P, Zheng YW, Liao GJ, Sun H, Wong J, Siu SS, Chan WC, Chan SL, Chan AT, Lai PB, Chiu RW, Lo YM. Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin Chem 2013; 59: 211-224 [PMID: 23065472 DOI: 10.1373/ clinchem.2012.196014]
79. Castells A, Puig P, Móra J, Boadas J, Boix L, Urgell E, Solé M, Capellà G, Lluís F, Fernández-Cruz L, Navarro S, Farré A. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance. J Clin Oncol 1999; 17: 578-584 [PMID: 10080602]
80. Diaz LA, Williams RT, Wu J, Kinde I, Hecht JR, Berlin J, Allen B, Bozic I, Reiter JG, Nowak MA, Kinzler KW, Oliner KS, Vogelstein B. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 2012; 486: 537-540 [PMID: 22722843 DOI: 10.1038/nature11219]
81. Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, Valtorta E, Schiavo R, Buscarino M, Siravegna G, Bencardino K, Cercek A, Chen CT, Veronese S, Zanon C, Sartore-Bianchi A, Gambacorta M, Gallicchio M, Vakiani E, Boscaro V, Medico E, Weiser M, Siena S, Di Nicolantonio F, Solit D, Bardelli A. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature 2012; 486: 532-536 [PMID: 22722830 DOI: 10.1038/na-ture11156]
82. Leary RJ, Kinde I, Diehl F, Schmidt K, Clouser C, Duncan C, Antipova A, Lee C, McKernan K, De La Vega FM, Kinzler KW, Vogelstein B, Diaz LA, Velculescu VE. Development of personalized tumor biomarkers using massively parallel sequencing. Sci Transl Med 2010; 2: 20ra14 [PMID: 20371490 DOI: 10.1126/scitranslmed.3000702]
83. Sai S, Ichikawa D, Tomita H, Ikoma D, Tani N, Ikoma H, Kikuchi S, Fujiwara H, Ueda Y, Otsuji E. Quantification of plasma cell-free DNA in patients with gastric cancer. Anti-cancer Res 2007; 27: 2747-2751 [PMID: 17695442]
84. Park JL, Kim HJ, Choi BY, Lee HC, Jang HR, Song KS, Noh SM, Kim SY, Han DS, Kim YS. Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients. Oncol Lett 2012; 3: 921-926 [PMID: 22741019 DOI: 10.3892/ol.2012.592]
85. Lee TL, Leung WK, Chan MW, Ng EK, Tong JH, Lo KW, Chung SC, Sung JJ, To KF. Detection of gene promoter hy-permethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res 2002; 8: 1761-1766 [PMID: 12060614]
86. Zheng Y, Chen L, Li J, Yu B, Su L, Chen X, Yu Y, Yan M, Liu B, Zhu Z. Hypermethylated DNA as potential biomarkers for gastric cancer diagnosis. Clin Biochem 2011; 44: 1405-1411 [PMID: 21945024 DOI: 10.1016/j.clinbiochem.2011.09.006]
87. Chen L, Su L, Li J, Zheng Y, Yu B, Yu Y, Yan M, Gu Q, Zhu Z, Liu B. Hypermethylated FAM5C and MYLK in serum as diagnosis and pre-warning markers for gastric cancer. Dis Markers 2012; 32: 195-202 [PMID: 22377736 DOI: 10.3233/ DMA-2011-0877]
88. Ling ZQ, Lv P, Lu XX, Yu JL, Han J, Ying LS, Zhu X, Zhu WY, Fang XH, Wang S, Wu YC. Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer. PLoS One 2013; 8: e67195 [PMID: 23826230 DOI: 10.1371/ journal.pone.0067195]
89. Gevensleben H, Garcia-Murillas I, Graeser MK, Schiavon G, Osin P, Parton M, Smith IE, Ashworth A, Turner NC. Noninvasive detection of HER2 amplification with plasma DNA digital PCR. Clin Cancer Res 2013; 19: 3276-3284 [PMID: 23637122 DOI: 10.1158/1078-0432.CCR-12-3768]
90. Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, Kinzler KW, Vogelstein B, Diaz LA. Circulating mutant DNA to assess tumor dynamics. Nat Med 2008; 14: 985-990 [PMID: 18670422 DOI: 10.1038/nm.1789]
91. Park KU, Lee HE, Park do J, Jung EJ, Song J, Kim HH, Choe G, Kim WH, Lee HS. MYC quantitation in cell-free plasma DNA by real-time PCR for gastric cancer diagnosis. Clin Chem Lab Med 2009; 47: 530-536 [PMID: 19302034 DOI: 10.1515/CCLM.2009.126]
92. Lee HE, Park KU, Yoo SB, Nam SK, Park do J, Kim HH, Lee HS. Clinical significance of intratumoral HER2 heterogeneity in gastric cancer. Eur J Cancer 2013; 49: 1448-1457 [PMID: 23146959 DOI: 10.1016/j.ejca.2012.10.018]
93. Reddi KK, Holland JF. Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci USA 1976; 73: 2308-2310 [PMID: 1065880]
94. Maor D, Mardiney MR. Alteration of human serum ribonu-clease activity in malignancy. CRC Crit Rev Clin Lab Sci 1978; 10: 89-111 [PMID: 752446]
95. Wieczorek AJ, Sitaramam V, Machleidt W, Rhyner K, Per-ruchoud AP, Block LH. Diagnostic and prognostic value of RNA-proteolipid in sera of patients with malignant disorders following therapy: frst clinical evaluation of a novel tumor marker. Cancer Res 1987; 47: 6407-6412 [PMID: 2445471]
96. Wieczorek AJ, Rhyner C, Block LH. Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans. Proc Natl Acad Sci USA 1985; 82: 3455-3459 [PMID: 2582412]
97. Kopreski MS, Benko FA, Kwak LW, Gocke CD. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 1999; 5: 1961-1965 [PMID: 10473072]
98. Lo KW, Lo YM, Leung SF, Tsang YS, Chan LY, Johnson PJ, Hjelm NM, Lee JC, Huang DP. Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin Chem 1999; 45: 1292-1294 [PMID: 10430801]
99. Dasí F, Martínez-Rodes P, March JA, Santamaría J, Mar-tínez-Javaloyas JM, Gil M, Aliño SF. Real-time quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer. Ann N Y Acad Sci 2006; 1075: 204-210 [PMID: 17108213 DOI: 10.1196/an-nals.1368.028]
100. Chen XQ, Bonnefoi H, Pelte MF, Lyautey J, Lederrey C, Movarekhi S, Schaeffer P, Mulcahy HE, Meyer P, Stroun M, Anker P. Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 2000; 6: 3823-3826 [PMID: 11051224]
101. Silva JM, Rodriguez R, Garcia JM, Muñoz C, Silva J, Domin-guez G, Provencio M, España P, Bonilla F. Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut 2002; 50: 530-534 [PMID: 11889075]
102. Houseley J, LaCava J, Tollervey D. RNA-quality control by the exosome. Nat Rev Mol Cell Biol 2006; 7: 529-539 [PMID: 16829983 DOI: 10.1038/nrm1964]
103. Simpson RJ, Jensen SS, Lim JW. Proteomic profling of exo-somes: current perspectives. Proteomics 2008; 8: 4083-4099 [PMID: 18780348 DOI: 10.1002/pmic.200800109]
104. Lee RC, Feinbaum RL, Ambros V. The C. elegans heteroch-ronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854 [PMID: 8252621]
105. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabdi-tis elegans. Nature 2000; 403: 901-906 [PMID: 10706289 DOI: 10.1038/35002607]
106. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Ku-roda MI, Maller B, Hayward DC, Ball EE, Degnan B, Müller P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, Levine M, Leahy P, Davidson E, Ruvkun G. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000; 408: 86-89 [PMID: 11081512 DOI: 10.1038/35040556]
107. Ghildiyal M, Zamore PD. Small silencing RNAs: an expanding universe. Nat Rev Genet 2009; 10: 94-108 [PMID: 19148191 DOI: 10.1038/nrg2504]
108. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115: 787-798 [PMID: 14697198]
109. Rajewsky N. microRNA target predictions in animals. Nat Genet 2006; 38 Suppl: S8-13 [PMID: 16736023 DOI: 10.1038/ ng1798]
110. Li C, Feng Y, Coukos G, Zhang L. Therapeutic microRNA strategies in human cancer. AAPS J 2009; 11: 747-757 [PMID: 19876744 DOI: 10.1208/s12248-009-9145-9]
111. Trang P, Weidhaas JB, Slack FJ. MicroRNAs as potential cancer therapeutics. Oncogene 2008; 27 Suppl 2: S52-S57 [PMID: 19956180 DOI: 10.1038/onc.2009.353]
112. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Bri-ant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518 [PMID: 18663219 DOI: 10.1073/ pnas.0804549105]
113. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY. Characterization of microRNAs in serum: a novel class of biomark-ers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006 [PMID: 18766170 DOI: 10.1038/cr.2008.282]
114. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Harris AL. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141: 672-675 [PMID: 18318758 DOI: 10.1111/j.1365-2141.2008.07077.x]
115. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 2008; 14: 2588-2592 [PMID: 18451220 DOI: 10.1158/1078-0432. CCR-07-0666]
116. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, Sun F, Lu J, Yin Y, Cai X, Sun Q, Wang K, Ba Y, Wang Q, Wang D, Yang J, Liu P, Xu T, Yan Q, Zhang J, Zen K, Zhang CY. Secreted mono-cytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010; 39: 133-144 [PMID: 20603081 DOI: 10.1016/ j.molcel.2010.06.010]
117. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011; 108: 5003-5008 [PMID: 21383194 DOI: 10.1073/pnas.1019055108]
118. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011; 13: 423-433 [PMID: 21423178 DOI: 10.1038/ncb2210]
119. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011; 39: 7223-7233 [PMID: 21609964 DOI: 10.1093/ nar/gkr254]
120. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Köppel T, Jahantigh MN, Lutgens E, Wang S, Olson EN, Schober A, Weber C. Delivery of microR-NA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009; 2: ra81 [PMID: 19996457 DOI: 10.1126/scisignal.2000610]
121. Ichikawa D, Komatsu S, Konishi H, Otsuji E. Circulating microRNA in digestive tract cancers. Gastroenterology 2012; 142: 1074-1078.e1 [PMID: 22433392 DOI: 10.1053/ j.gastro.2012.03.008]
122. Reid G, Kirschner MB, van Zandwijk N. Circulating microR-NAs: Association with disease and potential use as biomark-ers. Crit Rev Oncol Hematol 2011; 80: 193-208 [PMID: 21145252 DOI: 10.1016/j.critrevonc.2010.11.004]
123. Kang Y, Zhang J, Sun P, Shang J. Circulating cell-free human telomerase reverse transcriptase mRNA in plasma and its potential diagnostic and prognostic value for gastric cancer. Int J Clin Oncol 2013; 18: 478-486 [PMID: 22527847 DOI: 10.1007/s10147-012-0405-9]
124. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi K, Fujiwara H, Okamoto K, Otsuji E. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010; 102: 1174-1179 [PMID: 20234369 DOI: 10.1038/sj.bjc.6605608]
125. Konishi H, Ichikawa D, Komatsu S, Shiozaki A, Tsujiura M, Takeshita H, Morimura R, Nagata H, Arita T, Kawaguchi T, Hirashima S, Fujiwara H, Okamoto K, Otsuji E. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br J Cancer 2012; 106: 740-747 [PMID: 22262318 DOI: 10.1038/ bjc.2011.588]
126. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297 [PMID: 14744438]
127. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355 [PMID: 15372042 DOI: 10.1038/nature02871]
128. Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T, Fu-jiwara H, Okamoto K, Otsuji E. Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Res 2013; 33: 3185-3193 [PMID: 23898077 DOI: 33/8/3185]
129. Ørom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q, Gui-go R, Shiekhattar R. Long noncoding RNAs with enhancerlike function in human cells. Cell 2010; 143: 46-58 [PMID: 20887892 DOI: 10.1016/j.cell.2010.09.001]
130. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet 2009; 10: 155-159 [PMID: 19188922 DOI: 10.1038/nrg2521]
131. Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J, Fang G. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. FEBS J 2012; 279: 3159-3165 [PMID: 22776265 DOI: 10.1111/j.1742-4658.2012.08694.x]
132. Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y, Fang G. Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol 2013; 139: 437-445 [PMID: 23143645 DOI: 10.1007/ s00432-012-1324-x]
133. Funaki NO, Tanaka J, Kasamatsu T, Ohshio G, Hosotani R, Okino T, Imamura M. Identification of carcinoembryonic antigen mRNA in circulating peripheral blood of pancreatic carcinoma and gastric carcinoma patients. Life Sci 1996; 59: 2187-2199 [PMID: 8950323]
134. Mori M, Mimori K, Ueo H, Karimine N, Barnard GF, Sugi-machi K, Akiyoshi T. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 1996; 68: 739-743 [PMID: 8980176]
135. Aihara T, Noguchi S, Ishikawa O, Furukawa H, Hiratsuka M, Ohigashi H, Nakamori S, Monden M, Imaoka S. Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Int J Cancer 1997; 72: 408-411 [PMID: 9247282]
136. Soeth E, Vogel I, Röder C, Juhl H, Marxsen J, Krüger U, Henne-Bruns D, Kremer B, Kalthoff H. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 1997; 57: 3106-3110 [PMID: 9242433]
137. Yeh KH, Chen YC, Yeh SH, Chen CP, Lin JT, Cheng AL. Detection of circulating cancer cells by nested reverse tran-scription-polymerase chain reaction of cytokeratin-19 (K19)-possible clinical significance in advanced gastric cancer. Anticancer Res 1998; 18: 1283-1286 [PMID: 9615802]
138. Noh YH, Im G, Ku JH, Lee YS, Ahn MJ. Detection of tumor cell contamination in peripheral blood by RT-PCR in gastrointestinal cancer patients. J Korean Med Sci 1999; 14: 623-628 [PMID: 10642939]
139. Majima T, Ichikura T, Takayama E, Chochi K, Mochizuki H. Detecting circulating cancer cells using reverse transcriptase-polymerase chain reaction for cytokeratin mRNA in peripheral blood from patients with gastric cancer. Jpn J Clin Oncol 2000; 30: 499-503 [PMID: 11155920]
140. Noh YH, Kim JA, Lim GR, Ro YT, Koo JH, Lee YS, Han DS, Park HK, Ahn MJ. Detection of circulating tumor cells in patients with gastrointestinal tract cancer using RT-PCR and its clinical implications. Exp Mol Med 2001; 33: 8-14 [PMID: 11322488 DOI: 10.1038/emm.2001.2]
141. Sumikura S, Ishigami S, Natsugoe S, Miyazono F, Tokuda K, Nakajo A, Okumura H, Matsumoto M, Hokita S, Aikou T. Disseminated cancer cells in the blood and expression of si-alylated antigen in gastric cancer. Cancer Lett 2003; 200: 77-83 [PMID: 14550955]
142. Koike H, Ichikawa D, Ikoma H, Otsuji E, Kitamura K, Yam-agishi H. Comparison of methylation-specific polymerase chain reaction (MSP) with reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood of gastric cancer patients. J Surg Oncol 2004; 87: 182-186 [PMID: 15334633 DOI: 10.1002/jso.20106]
143. Friederichs J, Gertler R, Rosenberg R, Nahrig J, Führer K, Holzmann B, Dittler HJ, Dahm M, Thorban S, Nekarda H, Siewert JR. Prognostic impact of CK-20-positive cells in peripheral venous blood of patients with gastrointestinal carcinoma. World J Surg 2005; 29: 422-428 [PMID: 15770378 DOI: 10.1007/s00268-004-7662-3]
144. Illert B, Fein M, Otto C, Cording F, Stehle D, Thiede A, Timmermann W. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis. Scand J Gastroenterol 2005; 40: 843-849 [PMID: 16109661 DOI: 10.1080/00365520510015557]
145. Seo JH, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS, Lee SW, Choi JH, Park YT, Mok YJ, Kim CS, Kim JS. Follow-up study of peripheral blood carcinoembryonic antigen mRNA using reverse transcription-polymerase chain reaction as an early marker of clinical recurrence in patients with curatively resected gastric cancer. Am J Clin Oncol 2005; 28: 24-29 [PMID: 15685031]
146. Kolodziejczyk P, Pituch-Noworolska A, Drabik G, Kulig J, Szczepanik A, Sierzega M, Gurda A, Popiela T, Zembala M. The effects of preoperative chemotherapy on isolated tumour cells in the blood and bone marrow of gastric cancer patients. Br J Cancer 2007; 97: 589-592 [PMID: 17700573 DOI: 10.1038/sj.bjc.6603904]
147. Tani N, Ichikawa D, Ikoma D, Tomita H, Sai S, Ikoma H, Okamoto K, Ochiai T, Ueda Y, Otsuji E, Yamagishi H, Miura N, Shiota G. Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer. Anticancer Res 2007; 27: 1207-1212 [PMID: 17465264]
148. Koga T, Tokunaga E, Sumiyoshi Y, Oki E, Oda S, Takahashi I, Kakeji Y, Baba H, Maehara Y. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR. Hepatogastroenterology 2008; 55: 1131-1135 [PMID: 18705345]
149. Yie SM, Lou B, Ye SR, Cao M, He X, Li P, Hu K, Rao L, Wu SM, Xiao HB, Gao E. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Ann Surg Oncol 2008; 15: 3073-3082 [PMID: 18670822 DOI: 10.1245/s10434-008-0069-x]
150. Bertazza L, Mocellin S, Marchet A, Pilati P, Gabrieli J, Scalerta R, Nitti D. Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival. J Transl Med 2009; 7: 111 [PMID: 20028510 DOI: 10.1186/1479-5876-7-111]
151. Kita Y, Fukagawa T, Mimori K, Kosaka Y, Ishikawa K, Aik-ou T, Natsugoe S, Sasako M, Mori M. Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases. Br J Cancer 2009; 100: 153-159 [PMID: 19050704 DOI: 10.1038/sj.bjc.6604806]
152. Qiu MZ, Li ZH, Zhou ZW, Li YH, Wang ZQ, Wang FH, Huang P, Aziz F, Wang DY, Xu RH. Detection of carcinoem-bryonic antigen messenger RNA in blood using quantitative real-time reverse transcriptase-polymerase chain reaction to predict recurrence of gastric adenocarcinoma. J Transl Med 2010; 8: 107 [PMID: 21040522 DOI: 10.1186/1479-5876-8-107]
153. Saad AA, Awed NM, Abd Elkerim NN, El-Shennawy D, Al-fons MA, Elserafy ME, Darwish YW, Barakat EM, Ezz-Elarab SS. Prognostic signifcance of E-cadherin expression and peripheral blood micrometastasis in gastric carcinoma patients. Ann Surg Oncol 2010; 17: 3059-3067 [PMID: 20563657 DOI: 10.1245/s10434-010-1151-8]
154. Arigami T, Uenosono Y, Hirata M, Yanagita S, Ishigami S, Natsugoe S. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Cancer Sci 2011; 102: 1019-1024 [PMID: 21251161 DOI: 10.1111/j.1349-7006.2011.01877.x]
155. Cao W, Yang W, Li H, Lou G, Jiang J, Geng M, Xi W, Ren R, Qu Q, Jin X, Zhu Y, Jin Y. Using detection of survivin-expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer. J Surg Oncol 2011; 103: 110-115 [PMID: 21259243 DOI: 10.1002/jso.21777]
156. Dardaei L, Shahsavani R, Ghavamzadeh A, Behmanesh M, Aslankoohi E, Alimoghaddam K, Ghaffari SH. The detection of disseminated tumor cells in bone marrow and peripheral blood of gastric cancer patients by multimarker (CEA, CK20, TFF1 and MUC2) quantitative real-time PCR. Clin Biochem 2011; 44: 325-330 [PMID: 21130081 DOI: 10.1016/j.clinbioche m.2010.11.005]
157. Ren J, Chen Z, Juan SJ, Yong XY, Pan BR, Fan DM. Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique. Cancer 2000; 88: 280-285 [PMID: 10640958]
158. Lo YM, Chan WY, Ng EK, Chan LY, Lai PB, Tam JS, Chung SC. Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma. Clin Cancer Res 2001; 7: 1856-1859 [PMID: 11448896]
159. Kanyama Y, Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S, Nakao A. Detection of p16 promoter hypermethylation in serum of gastric cancer patients. Cancer Sci 2003; 94: 418-420 [PMID: 12824886]
160. Ichikawa D, Koike H, Ikoma H, Ikoma D, Tani N, Otsuji E, Kitamura K, Yamagishi H. Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer. Anticancer Res 2004; 24: 2477-2481 [PMID: 15330201]
161. Koike H, Ichikawa D, Ikoma H, Tani N, Ikoma D, Otsuji E, Okamoto K, Ueda Y, Kitamura K, Yamagishi H. Comparison of serum aberrant methylation and conventional tumor markers in gastric cancer patients. Hepatogastroenterology 2005; 52: 1293-1296 [PMID: 16001680]
162. Leung WK, To KF, Chu ES, Chan MW, Bai AH, Ng EK, Chan FK, Sung JJ. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer. Br J Cancer 2005; 92: 2190-2194 [PMID: 15942635 DOI: 10.1038/sj.bjc.6602636]
163. Ikoma H, Ichikawa D, Daito I, Nobuyuki T, Koike H, Oka-moto K, Ochiai T, Ueda Y, Yamagishi H, Otsuji E. Clinical application of methylation specific-polymerase chain reaction in serum of patients with gastric cancer. Hepatogastroen-terology 2007; 54: 946-950 [PMID: 17591100]
164. Tan SH, Ida H, Lau QC, Goh BC, Chieng WS, Loh M, Ito Y. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specifc polymerase chain reaction for tumour suppressor genes including RUNX3. Oncol Rep 2007; 18: 1225-1230 [PMID: 17914577]
165. Abbaszadegan MR, Moaven O, Sima HR, Ghafarzadegan K, A'rabi A, Forghani MN, Raziee HR, Mashhadinejad A, Jafarzadeh M, Esmaili-Shandiz E, Dadkhah E. p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. World J Gastroenterol 2008; 14: 2055-2060 [PMID: 18395906]
166. Kolesnikova EV, Tamkovich SN, Bryzgunova OE, She-lestyuk PI, Permyakova VI, Vlassov VV, Tuzikov AS, Lak-tionov PP, Rykova EY. Circulating DNA in the blood of gastric cancer patients. Ann N Y Acad Sci 2008; 1137: 226-231 [PMID: 18837952 DOI: 10.1196/annals.1448.009]
167. Wang YC, Yu ZH, Liu C, Xu LZ, Yu W, Lu J, Zhu RM, Li GL, Xia XY, Wei XW, Ji HZ, Lu H, Gao Y, Gao WM, Chen LB. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. World J Gastroenterol 2008; 14: 3074-3080 [PMID: 18494062]
168. Chen Z, Fan JQ, Li J, Li QS, Yan Z, Jia XK, Liu WD, Wei LJ, Zhang FZ, Gao H, Xu JP, Dong XM, Dai J, Zhou HM. Promoter hypermethylation correlates with the Hsulf-1 silencing in human breast and gastric cancer. Int J Cancer 2009; 124: 739-744 [PMID: 19006069 DOI: 10.1002/ijc.23960]
169. Sakakura C, Hamada T, Miyagawa K, Nishio M, Miyashita A, Nagata H, Ida H, Yazumi S, Otsuji E, Chiba T, Ito K, Ito Y. Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients. Anticancer Res 2009; 29: 2619-2625 [PMID: 19596937 DOI: 29/7/2619]
170. Zhang Y, Ye X, Geng J, Chen L. Epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in gastric and colorectal adenocarcinoma. Hepa-togastroenterology 2010; 57: 1614-1619 [PMID: 21443130]
171. Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H, Sanada Y. Detection of TFPI2 methylation in the serum of gastric cancer patients. Anticancer Res 2011; 31: 3835-3838 [PMID: 22110206]
172. Ng EK, Leung CP, Shin VY, Wong CL, Ma ES, Jin HC, Chu KM, Kwong A. Quantitative analysis and diagnostic signif-cance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients. PLoS One 2011; 6: e22233 [PMID: 21789241 DOI: 10.1371/journal.pone.0022233]
173. Raja UM, Gopal G, Rajkumar T. Intragenic DNA methyla-tion concomitant with repression of ATP4B and ATP4A gene expression in gastric cancer is a potential serum biomarker. Asian Pac J Cancer Prev 2012; 13: 5563-5568 [PMID: 23317218]
174. Shirahata A, Sakuraba K, Kitamura Y, Yokomizo K, Gotou T, Saitou M, Kigawa G, Nemoto H, Sanada Y, Hibi K. Detection of vimentin methylation in the serum of patients with gastric cancer. Anticancer Res 2012; 32: 791-794 [PMID: 22399595]
175. Balgkouranidou I, Karayiannakis A, Matthaios D, Bolanaki H, Tripsianis G, Tentes AA, Lianidou E, Chatzaki E, Fiska A, Lambropoulou M, Kolios G, Kakolyris S. Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival. Clin Chem Lab Med 2013; 51: 1505-1510 [PMID: 23403728 DOI: 10.1515/cclm-2012-0320]
176. Xu W, Zhou H, Qian H, Bu X, Chen D, Gu H, Zhu W, Yan Y, Mao F. Combination of circulating CXCR4 and Bmi-1 mRNA in plasma: A potential novel tumor marker for gastric cancer. Mol Med Rep 2009; 2: 765-771 [PMID: 21475899 DOI: 10.3892/ mmr_00000170]
177. Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, Huang D, Chen X, Zhang H, Zhuang R, Deng T, Liu H, Yin J, Wang S, Zen K, Ba Y, Zhang CY. A five-microRNA signature identi-fied from genome-wide serum microRNA expression profil-ing serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer 2011; 47: 784-791 [PMID: 21112772 DOI: 10.1016/ j.ejca.2010.10.025]
178. Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, Ma Y, Xiao H. Genome-wide microRNA profles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett 2012; 316: 196-203 [PMID: 22169097 DOI: 10.1016/ j.canlet.2011.10.034]
179. Song MY, Pan KF, Su HJ, Zhang L, Ma JL, Li JY, Yuasa Y, Kang D, Kim YS, You WC. Identification of serum microR-NAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One 2012; 7: e33608 [PMID: 22432036 DOI: 10.1371/journal.pone.0033608]
180. Tsai KW, Liao YL, Wu CW, Hu LY, Li SC, Chan WC, Ho MR, Lai CH, Kao HW, Fang WL, Huang KH, Lin WC. Aberrant expression of miR-196a in gastric cancers and correlation with recurrence. Genes Chromosomes Cancer 2012; 51: 394-401 [PMID: 22420029]
181. Wang B, Zhang Q. The expression and clinical significance of circulating microRNA-21 in serum of fve solid tumors. J Cancer Res Clin Oncol 2012; 138: 1659-1666 [PMID: 22638884 DOI: 10.1007/s00432-012-1244-9]
182. Wang M, Gu H, Wang S, Qian H, Zhu W, Zhang L, Zhao C, Tao Y, Xu W. Circulating miR-17-5p and miR-20a: molecular markers for gastric cancer. Mol Med Rep 2012; 5: 1514-1520 [PMID: 22406928 DOI: 10.3892/mmr.2012.828]
183. Zhang WH, Gui JH, Wang CZ, Chang Q, Xu SP, Cai CH, Li YN, Tian YP, Yan L, Wu B. The identification of miR-375 as a potential biomarker in distal gastric adenocarcinoma. Oncol Res 2012; 20: 139-147 [PMID: 23461060]
184. Gorur A, Balci Fidanci S, Dogruer Unal N, Ayaz L, Akbayir S, Yildirim Yaroglu H, Dirlik M, Serin MS, Tamer L. Determination of plasma microRNA for early detection of gastric cancer. Mol Biol Rep 2013; 40: 2091-2096 [PMID: 23212612 DOI: 10.1007/s11033-012-2267-7]
185. Kim SY, Jeon TY, Choi CI, Kim DH, Kim DH, Kim GH, Ryu DY, Lee BE, Kim HH. Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer. J Mol Diagn 2013; 15: 661-669 [PMID: 23806809 DOI: 10.1016/j.jmoldx.2013.04.004]
186. Komatsu S, Ichikawa D, Tsujiura M, Konishi H, Takeshita H, Nagata H, Kawaguchi T, Hirajima S, Arita T, Shiozaki A, Kubota T, Fujiwara H, Okamoto K, Otsuji E. Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. Anticancer Res 2013; 33: 271-276 [PMID: 23267156]
187. Li C, Li JF, Cai Q, Qiu QQ, Yan M, Liu BY, Zhu ZG. MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer. J Surg Oncol 2013; 108: 89-92 [PMID: 23733518 DOI: 10.1002/jso.23358]